{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:54:31Z","timestamp":1782827671352,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Alliance Cancer Control Program Junior Faculty Award","award":["UG1CA189823"],"award-info":[{"award-number":["UG1CA189823"]}]},{"name":"UC San Diego Clinical Translational Research Institute KL2 Career Development Award","award":["KL2TR001444"],"award-info":[{"award-number":["KL2TR001444"]}]},{"name":"Cambia Health Foundation Sojourns Scholar Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00520-020-05730-4","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T10:04:20Z","timestamp":1601373860000},"page":"2771-2775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FIT: Functional and imaging testing for patients with metastatic cancer"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-3573","authenticated-orcid":false,"given":"Eric J.","family":"Roeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Phull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hagmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Dullea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"El-Jawahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gallivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. D.","family":"Nipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E.","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"issue":"12","key":"5730_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","volume":"34","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA et al (2016) Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol 34(12):1339\u20131344","journal-title":"J Clin Oncol"},{"issue":"11","key":"5730_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","volume":"12","author":"AR Bruggeman","year":"2016","unstructured":"Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ (2016) Cancer cachexia: beyond weight loss. J Oncol Pract 12(11):1163\u20131171","journal-title":"J Oncol Pract"},{"issue":"3","key":"5730_CR3","first-page":"159","volume":"1","author":"MJ Tisdale","year":"2003","unstructured":"Tisdale MJ (2003) Pathogenesis of cancer cachexia. J Support Oncol 1(3):159\u2013168","journal-title":"J Support Oncol"},{"issue":"5","key":"5730_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","volume":"48","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A (2013) Cancer cachexia--pathophysiology and management. J Gastroenterol 48(5):574\u2013594","journal-title":"J Gastroenterol"},{"issue":"2","key":"5730_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7861\/clinmedicine.6-2-140","volume":"6","author":"GD Stewart","year":"2006","unstructured":"Stewart GD, Skipworth RJ, Fearon KC (2006) Cancer cachexia and fatigue. Clin Med (Lond) 6(2):140\u2013143","journal-title":"Clin Med (Lond)"},{"issue":"12","key":"5730_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00520-009-0776-2","volume":"18","author":"M Maddocks","year":"2010","unstructured":"Maddocks M, Byrne A, Johnson CD, Wilson RH, Fearon KC, Wilcock A (2010) Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study. Support Care Cancer 18(12):1539\u20131544","journal-title":"Support Care Cancer"},{"issue":"1","key":"5730_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1634\/theoncologist.2017-0255","volume":"23","author":"RD Nipp","year":"2018","unstructured":"Nipp RD, Fuchs G, El-Jawahri A et al (2018) Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 23(1):97\u2013104","journal-title":"Oncologist"},{"issue":"7","key":"5730_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","volume":"12","author":"J Bachmann","year":"2008","unstructured":"Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12(7):1193\u20131201","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"5730_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/jso.24025","volume":"112","author":"S Joglekar","year":"2015","unstructured":"Joglekar S, Nau PN, Mezhir JJ (2015) The impact of sarcopenia on survival and complications in surgical oncology: a review of the current literature. J Surg Oncol 112(5):503\u2013509","journal-title":"J Surg Oncol"},{"issue":"4","key":"5730_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13539-012-0075-5","volume":"3","author":"AE Utech","year":"2012","unstructured":"Utech AE, Tadros EM, Hayes TG, Garcia JM (2012) Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers. J Cachexia Sarcopenia Muscle 3(4):245\u2013251","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"5730_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1517\/14712598.2014.907788","volume":"14","author":"JD Ma","year":"2014","unstructured":"Ma JD, Heavey SF, Revta C, Roeland EJ (2014) Novel investigational biologics for the treatment of cancer cachexia. Expert Opin Biol Ther 14(8):1113\u20131120","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"5730_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17(4):519\u2013531","journal-title":"Lancet Oncol"},{"issue":"6","key":"5730_CR13","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z et al (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97(6):2333\u20132338","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"5730_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33(5):997\u20131006","journal-title":"Appl Physiol Nutr Metab"},{"issue":"5","key":"5730_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/JTO.0b013e31819e77e8","volume":"4","author":"G Kasymjanova","year":"2009","unstructured":"Kasymjanova G, Correa JA, Kreisman H, Dajczman E, Pepe C, Dobson S, Lajeunesse L, Sharma R, Small D (2009) Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol 4(5):602\u2013607","journal-title":"J Thorac Oncol"},{"issue":"2","key":"5730_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S (1991) The timed \u201cup & go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142\u2013148","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"5730_CR17","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L et al (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49(2):M85\u2013M94","journal-title":"J Gerontol"},{"issue":"2","key":"5730_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00520-015-2826-2","volume":"24","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen S, Ruijgrok C, Ostelo RW, de Vet HCW, Verheul HMW, de van der Schueren MAE, Langius JAE (2016) The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A\/CS and the VAS for appetite. Support Care Cancer 24(2):661\u2013666","journal-title":"Support Care Cancer"},{"issue":"2","key":"5730_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manag 13(2):63\u201374","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"5730_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495","journal-title":"Lancet Oncol"},{"key":"5730_CR21","doi-asserted-by":"crossref","unstructured":"Roeland E, Nelson S, Campillo A, et al. Inclusion criteria for cancer cachexia clinical trials: CT-defined skeletal muscle loss versus body weight loss. J Clin Oncol (Meeting Abstracts). 2015(suppl 29S; abstract 67)","DOI":"10.1200\/jco.2015.33.29_suppl.67"},{"issue":"4","key":"5730_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10278-017-9988-z","volume":"30","author":"H Lee","year":"2017","unstructured":"Lee H, Troschel FM, Tajmir S et al (2017) Pixel-level deep segmentation: artificial intelligence quantifies muscle on computed tomography for body morphometric analysis. J Digit Imaging 30(4):487\u2013498","journal-title":"J Digit Imaging"},{"key":"5730_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/978-3-030-01201-4_22","volume-title":"OR 2.0 Context-Aware Operating Theaters, Computer Assisted Robotic Endoscopy, Clinical Image-Based Procedures, and Skin Image Analysis","author":"CP Bridge","year":"2018","unstructured":"Bridge CP, Rosenthal M, Wright B et al (2018) Fully-automated analysis of body composition from CT in cancer patients using convolutional neural networks. In: OR 2.0 Context-Aware Operating Theaters, Computer Assisted Robotic Endoscopy, Clinical Image-Based Procedures, and Skin Image Analysis. Springer, Berlin, pp 204\u2013213"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05730-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05730-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05730-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:23:36Z","timestamp":1632875016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05730-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5730"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05730-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Roeland is a consultant for the BASF, Napo Pharmaceuticals, Imuneering, Asahi Kasei Pharma, Prime Oncology, and American Imaging Management. He also has served on advisory boards for Heron Therapeutics and Vector Oncology. He also serves on the Data Safety Monitoring Board for the Galera Therapeutics, Oragenics Inc., and Enzychem Lifesciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}